We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA), on 14 August 2019, for treating some of the most drug-resistant forms of tuberculosis (TB).
November 13-19, 2017 are the World Antibiotic Awareness Week determined by WTO. Antibiotics are essential resources for human health, however, their misuse is accelerating the emergence of bacteria resistant to their action, and deeply threatens the contr